PSDV - pSivida Corp.

NasdaqGM - NasdaqGM Delayed Price. Currency in USD

1.20

0.00 (0.00%)

At close: 4:00PM EDT

1.24 +0.04 (3.33%)
After hours: 7:57PM EDT

Stock chart is not supported by your current browser

Previous Close	1.20
Open	1.20
Bid	0.33 x 700
Ask	1.32 x 2000
Day's Range	1.18 - 1.25
52 Week Range	1.03 - 2.45
Volume	1,400,389
Avg. Volume	508,110

Market Cap	47.25M
Beta	-1.75
PE Ratio (TTM)	-2.19
EPS (TTM)	N/A
Earnings Date	N/A
Forward Dividend & Yield	N/A (N/A)
Ex-Dividend Date	N/A
1y Target Est	N/A

Trade prices are not sourced from all markets

All

News

Press Releases

Capital Cube11 hours ago
ETFs with exposure to pSivida Corp. : October 23, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Capital Cube19 days ago
pSivida Corp. :PSDV-US: Earnings Analysis: Q4, 2017 By the Numbers : October 5, 2017
Categories: Yahoo FinanceGet free summary analysis pSivida Corp. reports financial results for the quarter ended June 30, 2017. Highlights Summary numbers: Revenues of USD 0.70 million, Net Earnings of USD -6.12 million. Change in operating cash flow of -2.42% compared to same period last year is about the same as change in earnings, likely no significant movement ... Read more (Read more...)
Capital Cubelast month
ETFs with exposure to pSivida Corp. : September 18, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Capital Cubelast month
pSivida Corp. :PSDV-US: Earnings Analysis: 2017 By the Numbers : September 15, 2017
Categories: Yahoo FinanceGet free summary analysis pSivida Corp. reports financial results for the year ended June 30, 2017. We analyze the earnings along side the following peers of pSivida Corp. – Nektar Therapeutics, Regeneron Pharmaceuticals, Inc., Alimera Sciences, Inc., XOMA Corporation, Abbott Laboratories, Merck & Co., Inc., Heron Therapeutics Inc, Pfizer Inc. and Valeant Pharmaceuticals International Inc ... Read more (Read more...)
Thomson Reuters StreetEventslast month
Edited Transcript of PSDV earnings conference call or presentation 11-Sep-17 8:30pm GMT
Q4 2017 pSivida Corp Earnings Call
Simply Wall St.last month
Is pSivida Corp (PSDV) Undervalued?
pSivida Corp (NASDAQ:PSDV), a pharmaceuticals, biotechnology and life sciences company based in United States, Check out our latest analysis for pSivida Is PSDV still cheap? Good news, investors! PSDV isRead More...
Thomson Reuters StreetEvents5 months ago
Edited Transcript of PSDV earnings conference call or presentation 4-May-17 8:30pm GMT
Q3 2017 pSivida Corp Earnings Call
Capital Cube5 months ago
ETFs with exposure to pSivida Corp. : May 22, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Capital Cube5 months ago
ETFs with exposure to pSivida Corp. : May 11, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Capital Cube5 months ago
pSivida Corp. :PSDV-US: Earnings Analysis: Q3, 2017 By the Numbers : May 10, 2017
Categories: Yahoo FinanceGet free summary analysis pSivida Corp. reports financial results for the quarter ended March 31, 2017. We analyze the earnings along side the following peers of pSivida Corp. – Regeneron Pharmaceuticals, Inc., Alimera Sciences, Inc., Abbott Laboratories, Merck & Co., Inc. and Pfizer Inc. (REGN-US, ALIM-US, ABT-US, MRK-US and PFE-US) that have also reported for ... Read more (Read more...)
Associated Press6 months ago
PSivida reports 3Q loss
The Watertown, Massachusetts-based company said it had a loss of 15 cents per share. The drug delivery technology company posted revenue of $590,000 in the period. In the final minutes of trading on Thursday, ...
Capital Cube6 months ago
ETFs with exposure to pSivida Corp. : April 11, 2017
Categories: ETFs Yahoo FinanceClick here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Capital Cube7 months ago
ETFs with exposure to pSivida Corp. : March 30, 2017
Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Capital Cube7 months ago
pSivida Corp. :PSDV-US: Earnings Analysis: Q2, 2017 By the Numbers : March 20, 2017
Categories: Yahoo Finance Get free summary analysis pSivida Corp. reports financial results for the quarter ended December 31, 2016. We analyze the earnings along side the following peers of pSivida Corp. – Nektar Therapeutics, Regeneron Pharmaceuticals, Inc., Alimera Sciences, Inc., XOMA Corporation, Abbott Laboratories, Merck & Co., Inc., Heron Therapeutics Inc, Pfizer Inc. and Valeant Pharmaceuticals International Inc ... Read more (Read more...)
Thomson Reuters StreetEvents8 months ago
Edited Transcript of PSDV earnings conference call or presentation 7-Feb-17 9:30pm GMT
Q2 2017 pSivida Corp Earnings Call
Associated Press8 months ago
PSivida posts 2Q loss
On a per-share basis, the Watertown, Massachusetts-based company said it had a loss of less than 1 cent. The drug delivery technology company posted revenue of $6 million in the period. In the final minutes ...
Insider Monkey10 months ago
pSivida Corp. (PSDV): Here’s How It Stacks Up Versus Its Peers
We have been waiting for this for a year and finally the third quarter ended up showing a nice bump in the performance of small-cap stocks. Both the S&P 500 and Russell 2000 were up since the end of the second quarter, but small-cap stocks outperformed the large-cap stocks by double digits. This is important […]
Capital Cube10 months ago
ETFs with exposure to pSivida Corp. : December 13, 2016
Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Capital Cube11 months ago
ETFs with exposure to pSivida Corp. : December 2, 2016
Categories: ETFs Yahoo Finance Click here to see latest analysis ETFs with exposure to pSivida Corp. Here are 5 ETFs with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETFs that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Capital Cube11 months ago
ETF’s with exposure to pSivida Corp. : November 10, 2016
Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to pSivida Corp. Here are 5 ETF’s with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)
Capital Cube11 months ago
pSivida Corp. :PSDV-US: Earnings Analysis: Q1, 2017 By the Numbers : November 9, 2016
Categories: Yahoo Finance Get free summary analysis pSivida Corp. reports financial results for the quarter ended September 30, 2016. We analyze the earnings along side the following peers of pSivida Corp. – Nektar Therapeutics, Regeneron Pharmaceuticals, Inc., Alimera Sciences, Inc., Abbott Laboratories, Merck & Co., Inc. and Pfizer Inc. (NKTR-US, REGN-US, ALIM-US, ABT-US, MRK-US and PFE-US) that have ... Read more (Read more...)
Capital Cubelast year
ETF’s with exposure to pSivida Corp. : October 28, 2016
Categories: ETFs Yahoo Finance Click here to see latest analysis ETF’s with exposure to pSivida Corp. Here are 5 ETF’s with the largest exposure to PSDV-US. Comparing the performance and risk of pSivida Corp. with the ETF’s that have exposure to it gives us some ETF choices that could give us similar returns with lower volatility. Ticker Fund Name ... Read more (Read more...)